Larroquette, M.; Lefort, F.; Domblides, C.; Héraudet, L.; Robert, G.; Ravaud, A.; Gross-Goupil, M.
How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma. Cancers 2024, 16, 1780.
https://doi.org/10.3390/cancers16091780
AMA Style
Larroquette M, Lefort F, Domblides C, Héraudet L, Robert G, Ravaud A, Gross-Goupil M.
How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma. Cancers. 2024; 16(9):1780.
https://doi.org/10.3390/cancers16091780
Chicago/Turabian Style
Larroquette, Mathieu, Félix Lefort, Charlotte Domblides, Luc Héraudet, Grégoire Robert, Alain Ravaud, and Marine Gross-Goupil.
2024. "How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma" Cancers 16, no. 9: 1780.
https://doi.org/10.3390/cancers16091780
APA Style
Larroquette, M., Lefort, F., Domblides, C., Héraudet, L., Robert, G., Ravaud, A., & Gross-Goupil, M.
(2024). How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma. Cancers, 16(9), 1780.
https://doi.org/10.3390/cancers16091780